COMMUNIQUÉS West-GlobeNewswire

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 mai 2018
06/06/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 mai 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France (le [...]
VALNEVA : Déclaration d'actions et de droits de vote - MAI 2018
06/06/2018
VALNEVA Déclaration d'actions et de droits de vote - MAI 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
Michael Feltes, MD is Appointed to the American Health Council’s Board of Physicians
06/06/2018
NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- The American Health Council has appointed Michael Feltes, MD to its Board of Physicians for his outstanding contributions to the medical field. Dr. Feltes is the founder of [...]
NANOBIOTIX' Management statement on recent share price variation
06/06/2018
NANOBIOTIX' MANAGEMENT STATEMENT ON RECENT SHARE PRICE VARIATION Paris, France and Cambridge, Massachusetts, USA, June 6 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine [...]
NANOBIOTIX : Déclaration à la suite de la variation récente du prix de l'action
06/06/2018
NANOBIOTIX : DECLARATION A LA SUITE DE LA VARIATION RECENTE DU PRIX DE L'ACTION Paris, France et Cambridge, Massachusetts, USA, 6 juin 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), société française pionnière [...]
CohBar to Hold 2018 Annual Shareholder Meeting and Investor Update, June 19, 2018
06/06/2018
MENLO PARK, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (“CohBar” or the “Company”), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related [...]
Moleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa
06/06/2018
HOUSTON, June 06, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
FlexDex, Inc. Appoints New Vice President, Research and Development and Vice President, International Sales and Marketing
06/06/2018
BRIGHTON, Mich., June 06, 2018 (GLOBE NEWSWIRE) -- FlexDex, Inc. (“FlexDex” or “Company”), a medical device company that is developing a platform of articulating laparoscopic instruments for minimally invasive surgery, [...]
FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon
06/06/2018
No Reports of Deaths Related to Use of Obalon Six-Month Balloon System SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated medical [...]
CEO Ronan O’Caoimh Increases Shareholding in Trinity Biotech
06/06/2018
DUBLIN, Ireland, June 06, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), today announced that Ronan O’Caoimh, CEO of Trinity Biotech, has increased his shareholding in Trinity Biotech by the acquisition of [...]
Abeona Therapeutics Announces Upcoming Presentation at Jefferies 2018 Global Healthcare Conference
06/06/2018
Company CEO to Present on Thursday, June 7th at 11:00 AM ET NEW YORK and CLEVELAND, June 06, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on [...]
Navamedic ASA: Share option program
06/06/2018
On the basis of the approval by the Annual General Meeting of June 6 th 2017, to authorize the Board to issue 150 000 new shares to management under a long-term incentive program, the Board has now resolved to issue [...]
Avenue Therapeutics to Host Key Opinion Leader Call on Intravenous (IV) Tramadol for the Management of Postoperative Pain
06/06/2018
Neil Singla, M.D., Lotus Clinical Research, and Harold Minkowitz, M.D., HD Research Corporation, to participate in call on Monday, June 11, 2018, at 11 a.m. EDT NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Avenue [...]
Natus Annual Meeting - What’s at Stake?
06/06/2018
Natus Continues to Believe Voce’s Actions Indicate Its Desire to Take Control of the Natus Board, Fire the CEO and Halt Execution of the Company’s Successful Strategy The Natus Board Urges Shareholders to Vote the WHITE [...]
Terra Tech Corp. Begins IVXX Cultivation at New Sparks, Nevada Facility
06/06/2018
IRVINE, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp . (OTCQX:TRTC), a vertically integrated cannabis-focused agriculture company, is pleased to announce that it has commenced cultivation at its new Sparks [...]
Cesca Therapeutics Announces Exhibition at The Orthobiologic Institute’s 9th Annual PRP & Regenerative Medicine Symposium
06/06/2018
Company’s device subsidiary, ThermoGenesis, to exhibit its novel PXP™ cellular processing system at Booth 208 RANCHO CORDOVA, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company [...]
Daré Bioscience, Inc. Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Officer
06/06/2018
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of David Friend, Ph.D., to the newly created role of [...]
FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Rhabdomyosarcoma
06/06/2018
MADISON, Wis., June 06, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]
Vedantra Pharmaceuticals Names Gregory I. Berk President and Chief Medical Officer
06/06/2018
CAMBRIDGE, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products to treat cancer and infectious disease, today announced the appointment of [...]

Pages